STOCK TITAN

CNS Pharmaceuticals, Inc. (CNSP) Free Cash Flow by Year

CNSP

CNS Pharmaceuticals, Inc. recorded an outflow of $13.8M in free cash flow in fiscal year 2025. This represents an increase of 19.2% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters CNS Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Free Cash Flow -$13.8M
YoY +19.2%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CNSP Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25DEF 14AFY24DEF 14AFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-K
Free Cash Flow-$13.8M+19.2%-$17.1MN/A-$10.6M+22.0%-$13.5M-84.6%-$7.3M-105.3%-$3.6M-398.8%-$716K

CNSP Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Free Cash Flow-$3.5M+33.7%-$4.7M-43.6%N/AN/A-$5.3M-$3.2M-$5.5M-115.7%N/AN/AN/A-$2.5M-10.1%-$3.4M-86.2%

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More CNS Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was CNS Pharmaceuticals, Inc.'s free cash flow in fiscal year 2025?

CNS Pharmaceuticals, Inc. recorded an outflow of $13.8M in free cash flow in fiscal year 2025.

How fast is CNS Pharmaceuticals, Inc.'s free cash flow growing?

CNS Pharmaceuticals, Inc. (CNSP) free cash flow rose by 19.2% year over year, from -$17.1M to -$13.8M in fiscal year 2025.

How has CNS Pharmaceuticals, Inc.'s free cash flow changed over the years?

Across the 8 fiscal years this page covers, CNS Pharmaceuticals, Inc. (CNSP) free cash flow went from -$716K in fiscal year 2018 to -$13.8M in fiscal year 2025.

CNS Pharmaceuticals, Inc. (CNSP) reported -$3.5M in free cash flow in Q2 2026. This represents an increase of 33.7% from the same quarter a year earlier.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what CNS Pharmaceuticals, Inc. (CNSP) reported on that line in every period on record.